Oseltamivir Phosphate
NDC 70771-1598, Oseltamivir Acid, suspension, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1598
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209113
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1598 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OSELTAMIVIR PHOSPHATE6 mg/mL
Pharmacologic classes
Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1598-6 | 70771159806 | 60 mL in 1 BOTTLE (70771-1598-6) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7c0923ad-80b0-4134-b44a-754ea599f356
Use it
Look up 70771-1598 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1598 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1598. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.